Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2026.08.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Fei Ji und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Cellular Reprogramming, Lung Neoplasms, Myeloid Cells, Myeloid-Derived Suppressor Cells. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
- Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, Chicago, IL 60637, USA.
- Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, C…
- Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
- Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA. Electronic address: hualiang@uchicago.edu.
- Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, Chicago, IL 60637, USA; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 6…
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- National Institutes of Health
- Foundation for the National Institutes of Health
- HHMI
Zitieren
APA
Ji, F., Zheng, L., Chen, D., Xia, P., Zou, Z., Liu, W., Bugno, J., Naccasha, E. Z., Piffkó, A., Wen, C., Li, K., Xu, L., Luo, S. Z., Huang, X., Wang, J., Ju, C., Liu, B., Ji, Y., Li, H., …, & Weichselbaum, R. R. (2026). Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.08.017
Vancouver
Ji F, Zheng L, Chen D, Xia P, Zou Z, Liu W, et al. Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.08.017
BibTeX
@article{Ji2026,
author = {Ji, Fei and Zheng, Lei and Chen, Dapeng and Xia, Peng and Zou, Zhongyu and Liu, Wei and Bugno, Jason and Naccasha, Emile Z and Piffkó, András and Wen, Chuangyu and Li, Kangdi and Xu, Liping and Luo, Sean Z and Huang, Xiaona and Wang, Jiaai and Ju, Chengwei and Liu, Bei and Ji, Yiyi and Li, Han and Chmura, Steven J and Pitroda, Sean P and Liang, Hua Laura and He, Chuan and Weichselbaum, Ralph R},
title = {Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.08.017}
}
EUVIMED